Mechanisms of Resistence of New Target Drugs in Acute Myeloid Leukemia

New drugs targeting single mutations have been recently approved for Acute Myeloid Leukemia (AML) treatment, but allogeneic transplant still remains the only curative option in intermediate and unfavorable risk settings, because of the high incidence of relapse. Molecular analysis repertoire permits...

Descripción completa

Detalles Bibliográficos

Autores principales:	Capelli, Debora, Saraceni, Francesco, Menotti, Diego, Fiorentini, Alessandro, Olivieri, Attilio
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2020
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/74391
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!